Ronald Carnemolla

600 total citations
14 papers, 521 citations indexed

About

Ronald Carnemolla is a scholar working on Hematology, Molecular Biology and Internal Medicine. According to data from OpenAlex, Ronald Carnemolla has authored 14 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Internal Medicine. Recurrent topics in Ronald Carnemolla's work include Blood Coagulation and Thrombosis Mechanisms (10 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Ronald Carnemolla is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (10 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Ronald Carnemolla collaborates with scholars based in United States and Poland. Ronald Carnemolla's co-authors include Vladimir R. Muzykantov, Domenico Accili, Seongah Han, Chien-Ping Liang, Haruka Okamoto, Alan R. Tall, Ira Tabas, Colin F. Greineder, Douglas B. Cines and Charles T. Esmon and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Ronald Carnemolla

14 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald Carnemolla United States 11 190 114 109 104 100 14 521
Lauren Koniaris United States 6 166 0.9× 64 0.6× 46 0.4× 96 0.9× 55 0.6× 8 549
Herrmann Switzerland 6 72 0.4× 129 1.1× 117 1.1× 25 0.2× 97 1.0× 13 446
Patali S. Cheruku United States 7 400 2.1× 55 0.5× 104 1.0× 50 0.5× 324 3.2× 10 774
Tessa M. Simone United States 12 305 1.6× 44 0.4× 59 0.5× 69 0.7× 48 0.5× 20 608
Asako Tajima United States 12 158 0.8× 119 1.0× 40 0.4× 27 0.3× 74 0.7× 18 450
Anne Barbara Tietz Germany 8 186 1.0× 70 0.6× 71 0.7× 23 0.2× 39 0.4× 10 488
Yoshiharu Tokunaga Japan 14 265 1.4× 69 0.6× 83 0.8× 11 0.1× 45 0.5× 39 661
Samira Tliba United States 10 157 0.8× 184 1.6× 27 0.2× 89 0.9× 99 1.0× 10 527
Robert F. Moore United States 12 177 0.9× 45 0.4× 48 0.4× 17 0.2× 127 1.3× 23 601

Countries citing papers authored by Ronald Carnemolla

Since Specialization
Citations

This map shows the geographic impact of Ronald Carnemolla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Carnemolla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Carnemolla more than expected).

Fields of papers citing papers by Ronald Carnemolla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Carnemolla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Carnemolla. The network helps show where Ronald Carnemolla may publish in the future.

Co-authorship network of co-authors of Ronald Carnemolla

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Carnemolla. A scholar is included among the top collaborators of Ronald Carnemolla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Carnemolla. Ronald Carnemolla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Carnemolla, Ronald, Carlos H. Villa, Colin F. Greineder, et al.. (2016). Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia‐reperfusion injury. The FASEB Journal. 31(2). 761–770. 28 indexed citations
2.
Greineder, Colin F., Ronald Carnemolla, С. В. Зайцев, et al.. (2015). Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect. The FASEB Journal. 29(8). 3483–3492. 24 indexed citations
3.
Villa, Carlos H., Colin F. Greineder, Ian Johnston, et al.. (2015). Thrombomodulin Fusion Proteins Coupled to Human Erythrocytes Demonstrate Anti-Thrombotic and Anti-Inflammatory Activity. Blood. 126(23). 3493–3493. 1 indexed citations
4.
Greineder, Colin F., Ann‐Marie Chacko, Blaine J. Zern, et al.. (2013). Vascular Immunotargeting to Endothelial Determinant ICAM-1 Enables Optimal Partnering of Recombinant scFv-Thrombomodulin Fusion with Endogenous Cofactor. PLoS ONE. 8(11). e80110–e80110. 42 indexed citations
5.
Carnemolla, Ronald, Colin F. Greineder, Ann‐Marie Chacko, et al.. (2013). Platelet Endothelial Cell Adhesion Molecule Targeted Oxidant-Resistant Mutant Thrombomodulin Fusion Protein with Enhanced Potency In Vitro and In Vivo. Journal of Pharmacology and Experimental Therapeutics. 347(2). 339–345. 15 indexed citations
6.
Greineder, Colin F., Melissa D. Howard, Ronald Carnemolla, Douglas B. Cines, & Vladimir R. Muzykantov. (2013). Advanced drug delivery systems for antithrombotic agents. Blood. 122(9). 1565–1575. 78 indexed citations
7.
Sontag, Timothy J., Ronald Carnemolla, Tomáš Vaisar, Catherine A. Reardon, & Godfrey S. Getz. (2012). Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein. Journal of Lipid Research. 53(5). 951–963. 10 indexed citations
8.
Carnemolla, Ronald, K R Patel, С. В. Зайцев, et al.. (2012). Quantitative analysis of thrombomodulin-mediated conversion of protein C to APC: Translation from in vitro to in vivo. Journal of Immunological Methods. 384(1-2). 21–24. 12 indexed citations
9.
Зайцев, С. В., M. Anna Kowalska, Ronald Carnemolla, et al.. (2012). Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis. Blood. 119(20). 4779–4785. 63 indexed citations
10.
Carnemolla, Ronald & Vladimir R. Muzykantov. (2011). Vascular targeting of antithrombotic agents. IUBMB Life. 63(8). 632–639. 9 indexed citations
11.
Carnemolla, Ronald, Vladimir V. Shuvaev, & Vladimir R. Muzykantov. (2010). Targeting Antioxidant and Antithrombotic Biotherapeutics to Endothelium. Seminars in Thrombosis and Hemostasis. 36(3). 332–342. 21 indexed citations
12.
Carnemolla, Ronald, Xuefeng Ren, Tapan Biswas, et al.. (2008). The Specific Amino Acid Sequence between Helices 7 and 8 Influences the Binding Specificity of Human Apolipoprotein A-I for High Density Lipoprotein (HDL) Subclasses. Journal of Biological Chemistry. 283(23). 15779–15788. 13 indexed citations
13.
Liang, Chien-Ping, Seongah Han, Haruka Okamoto, et al.. (2004). Increased CD36 protein as a response to defective insulin signaling in macrophages. Journal of Clinical Investigation. 113(5). 764–773. 186 indexed citations
14.
Liang, Chien-Ping, Seongah Han, Haruka Okamoto, et al.. (2004). Increased CD36 protein as a response to defective insulin signaling in macrophages. Journal of Clinical Investigation. 113(5). 764–773. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026